why choose us

Clinical Trials Search

Showing 11,260 of 132,366 result(s)
Increasing PrEP Awareness and Demand Among Black Cisgender Women

Status: NOT_YET_RECRUITING

Condition: HIV

Interventions: Community-designed PrEP awareness materials - developed in the formative portion of this study

Date: 2023-05-31

European Aortic Data Collection Project

Status: Completed

Condition: Complex Abdominal Aortic Aneurysm

Interventions: Use of Cook's custom-made endovascular grafts to treat complex abdominal, thoracoabdominal aortic diseases, or aortic arch diseases such as aneur

Date: 2023-05-31

A Phase 1;2 Study of Personalized PSMA Radiopharmaceutical Therapy

Status: NOT_YET_RECRUITING

Condition: Cancer

Interventions: Personalized 177Lu-PSMA-I&T injected activity

Date: 2023-05-31

Shockwave Lithotripsy (SWL) Versus SWL and Oral Dissolution Therapy (ODT) For Paediatrics Radiolucent Renal Stone

Status: COMPLETED

Condition: Pediatric Kidney Disease

Interventions: Shockwave Lithotripsy (SWL) For Paediatrics Radiolucent Renal Stone

Date: 2023-05-31

rTMS in Older Adults With MCI and AUD

Status: NOT_YET_RECRUITING

Condition: Alcohol Use Disorder

Interventions: Participants in this group will receive 10 sessions of iTBS-rTMS per day, 5 days per week for one week (50 sessions total)

Date: 2023-05-31

Cerebral Monitoring Using Pulsatile Near Infrared Spectroscopy in Neonates

Status: Completed

Condition: Neonatal Disease

Interventions: No intervention

Date: 2023-05-31

Kisspeptin Administration Subcutaneously to Patients With IHH

Status: Completed

Condition: Hypogonadotropic Hypogonadism

Interventions: SC administration of kisspeptin for two weeks (pulsatile, every 60-240 minutes)

Date: 2023-05-31

Effect of ECPP on Recurrent Bile Duct Stones

Status: Completed

Condition: Sphincterotomy, Endoscopic

Interventions: Stones are taken by cutting the papillary sphincter

Date: 2023-05-31

Study of MAR001 in Adults With Metabolic Dysfunction

Status: NOT_YET_RECRUITING

Condition: Hypertriglyceridemia

Interventions: Subcutaneous injection

Date: 2023-05-31